UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050144
Receipt number R000057098
Scientific Title An Observation study for investing the relationship between hypoxia imaging endoscopy and the density of bile acid in colon, and clinical symptoms
Date of disclosure of the study information 2023/01/26
Last modified on 2023/07/22 22:41:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Observation study for investing the relationship between hypoxia imaging endoscopy and the density of bile acid in colon, and clinical symptoms

Acronym

An observation study for the relationship between hypoxia imaging endoscopy and the density of bile acid in colon, and clinical symptoms

Scientific Title

An Observation study for investing the relationship between hypoxia imaging endoscopy and the density of bile acid in colon, and clinical symptoms

Scientific Title:Acronym

An Observation study for investing the relationship between hypoxia imaging endoscopy and the density of bile acid in colon, and clinical symptoms

Region

Japan


Condition

Condition

Abnormal defecation due to high or low bile acid

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether the bilirubin signal value in the intestinal tract detected using the novel endoscopy system EP-0002 is consistent with the intestinal fluid bilirubin concentration.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Correlation between bile pixel values measured in image enhancement mode and bile concentration in intestinal fluid

Key secondary outcomes

Correlation between pixel values measured in image enhancement mode and abdominal symptoms
Correlation between pixel values measured in image-enhanced mode and blood bile markers


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1) Undergo lower gastrointestinal endoscopy
2) Patients with no history of gastrointestinal surgery including cholecystectomy

Key exclusion criteria

(1) Inability to obtain written consent

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takuma
Middle name
Last name Higurashi

Organization

Yokohama City University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

236-0004

Address

3-9 Fukuura Kanazawa Yokohama Kanagawa

TEL

045-787-2640

Email

takuma_h@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Takuma
Middle name
Last name Higurashi

Organization

Yokohama City University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

236-0004

Address

3-9 Fukuura Kanazawa Yokohama Kanagawa

TEL

0457872640

Homepage URL


Email

takuma_h@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University Hopspital IRB

Address

3-9 Fukuura Kanazawa Yokohama Kanagawa

Tel

045-370-7627

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 11 Month 15 Day

Date of IRB

2023 Year 01 Month 20 Day

Anticipated trial start date

2023 Year 01 Month 26 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observation study


Management information

Registered date

2023 Year 01 Month 26 Day

Last modified on

2023 Year 07 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057098


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name